ScreenPoint Medical Funding Round

4/17/2026

Debt
Venture Equity

$16,000,000

Undisclosed

This funding will support continued product innovation, international expansion, and strategic initiatives that strengthen ScreenPoint Medical's position as a trusted partner in the future of breast cancer care.

Private & Independent

Healthcare IT

Toernooiveld 300
Nijmegen, 6525 EC
The Netherlands

We are bringing AI to the fight against breast cancer with leading clinical evidence and the latest deep learning technology. At ScreenPoint, we know that breast imaging -- and particularly breast screening -- cannot function without effective workflow. To support our customers, we have designed an offering that is flexible and environment agnostic. Transpara works on 2D and 3D acquisitions, and our detection algorithm works on gantries from every major manufacturer. Regardless of your workflow, we want to fit seamlessly into your toolkit, so we work hard to ensure a seamless integration regardless of acquisition and reading environments.